Concepedia

Eftyhia Vardas

EV

35

Publications

3K

Citations

26

H-Index

1970

Active since

Affiliations

University of the Witwatersrand(Current)

Stellenbosch University

Perinatal HIV Research Unit

Merck & Co., Inc., Rahway, NJ, USA (United States)

Lancet Laboratories

Eftyhia Vardas is an author at University of the Witwatersrand specializing in medicine, vaccination, and immunology.

ORCID

Top concepts

Publications per year

1970–2020

35

Publications

35

Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males

Anna R. Giuliano, Joel M. Palefsky, Stephen E. Goldstone et al. · New England Journal of Medicine · 2011 · 1.1K citations · Full text

International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials

T. Christopher Mast, Lisa Kierstead, Swati B. Gupta et al. · Vaccine · 2009 · 276 citations

, , +10

Prevalence of Neutralizing Antibodies to Adenoviral Serotypes 5 and 35 in the Adult Populations of The Gambia, South Africa, and the United States

Edward Nwanegbo, Eftyhia Vardas, Wentao Gao et al. · Clinical and Vaccine Immunology · 2004 · 265 citations · Full text

External Genital Human Papillomavirus Prevalence and Associated Factors Among Heterosexual Men on 5 Continents

Eftyhia Vardas, Anna R. Giuliano, S. Goldstone et al. · The Journal of Infectious Diseases · 2010 · 115 citations · Full text

Immunogenicity of the Quadrivalent Human Papillomavirus (Type 6/11/16/18) Vaccine in Males 16 to 26 Years Old

Richard J. Hillman, Anna R. Giuliano, Joel M. Palefsky et al. · Clinical and Vaccine Immunology · 2011 · 112 citations · Full text

, , +19

Rows per page

1–5 of 35